Graves` & Thyroid Disease National Patient Conference

The leading cause of hyperthyroidism, Graves` disease represents a
basic defect in the immune system, causing production of
immunoglobulins (antibodies), which stimulate and attack the thyroid
gland, causing growth of the gland and overproduction of thyroid
hormone. Similar antibodies may also attack the tissues in the eye
muscles and in the pretibial skin (the skin on the front of the lower
leg). Graves` Disease affects two out of every 100 women but less
common in men.

The Conference will focus on Graves` disease
symptoms & treatment, hypothyroidism & hyperthyroidism,
thyroid-related eye conditions; and an update on the latest Graves`
disease research. Also workshops on the emotional and psychological
impact of Graves` disease. You`ll meet other patients coping with
Graves` and thyroid-related illnesses.

Dr. Terry Smith, who is
Chief Medical & Scientific Officer of the Graves` Disease
Foundation and Professor of Medicine, at Harbor-UCLA Medical Center
& The David Geffen School of Medicine at UCLA; is Conference Chair
for this year`s meeting.

Dr. Smith announced the following keynote physicians and renowned experts will speak at the Conference:

Raymond Douglas, MD

Jules Stein Eye Institute

Michael Kazim, MD

Columbia University, NY

Don O. Kikkawa, MD

Shiley Eye Center, La Jolla, CA.

Ira Lesser, MD

Harbor-UCLA Medical Ctr.

Some thyroid topics will be:

  • The Scientific basis for Graves` disease: how little we really know!
  • Medical & surgical approaches to hyperthyroidism
  • Modern approaches to double vision in Graves` ophthalmology
  • Bony decompression for Graves` opthalmopathy
  • The emotional impact of Graves` disease on patients and their families
  • The role of Steroids & Radiotherapy in Graves` opthalmopathy
  • New therapeutic approaches for Graves` disease on the horizon

For more Conference details, call the Graves` Disease Foundation`s toll-free 1 (877) NGDF-123, or its website:

Receive a free Graves` disease pamphlet or newsletter, send an email to: [email protected].


Peter Filocamo

Graves` Disease Foundation,